LncRNA Bmncr alleviates the progression of osteoporosis by inhibiting RANML-induced osteoclast differentiation

European review for medical and pharmacological sciences, pp. 9199-9206, 2019.

Cited by: 0|Bibtex|Views10|DOI:https://doi.org/10.26355/eurrev_201911_19411
WOS
Other Links: pubmed.ncbi.nlm.nih.gov|academic.microsoft.com

Abstract:

LncRNA Bmncr inhibits RANKL-induced osteoclast differentiation, thus alleviating the progression of osteoporosis.

Code:

Data:

Your rating :
0

 

Tags
Comments